Linda Burkly
Chief Tech/Sci/R&D Officer chez EDITAS MEDICINE, INC.
Fortune : 630 863 $ au 31/03/2024
Profil
Linda C.
Burkly is currently the Chief Scientific Officer & Executive VP at Editas Medicine, Inc. Prior to her current position, she worked at Biogen, Inc. as the Vice President & Senior Distinguished Investigator from 2014 to 2022.
Burkly received her undergraduate degree from Fairfield University and her doctorate from Tufts University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EDITAS MEDICINE, INC.
0,10% | 02/03/2024 | 85 022 ( 0,10% ) | 630 863 $ | 31/03/2024 |
Postes actifs de Linda Burkly
| Sociétés | Poste | Début |
|---|---|---|
| EDITAS MEDICINE, INC. | Chief Tech/Sci/R&D Officer | 24/07/2023 |
Anciens postes connus de Linda Burkly
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2022 |
Formation de Linda Burkly
| Fairfield University | Undergraduate Degree |
| Tufts University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
